» Articles » PMID: 29992733

Monitoring Chemotherapy-induced Alopecia with Trichoscopy

Overview
Specialty Dermatology
Date 2018 Jul 12
PMID 29992733
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Chemotherapy-induced alopecia (CIA) ranks among the psychologically most devastating effects of cancer treatment for oncological patients, with an overall incidence of 65%. Nowadays trichoscopy is largely employed in the diagnosis of alopecia, but no description of CIA trichoscopic pattern is present in literature.

Aims: We want to create an organic description of CIA trichoscopic aspects.

Methods: Oncological patients candidate to chemotherapy drugs, afferent to our trichological outpatient were studied. Anamnesis, clinical exam, clinical global photography, pull test, trichogram, and trichoscopy were conducted at the different moments of therapeutic treatment.

Results: A definite trichoscopic pattern in the different phases of treatment was observed. After the first 3 weeks of chemotherapy rare and scattered black dots, broken hairs, flame hairs and pohl pinkus appeared. At the end of chemotherapy besides the features described above, numerous thin hair in regrowth were detected, together to rare terminal hair, scattered black dots and circle hair. Three months after chemotherapy a progressive increase of follicular units and elongation of the existing hair were visible.

Conclusions: We propose an description of CIA trichoscopic pattern and its evolution during the different phases of chemotherapy.

Citing Articles

Defining Predictive Factors for Permanent Chemotherapy-Induced Alopecia: Trichoscopy, Reflectance Confocal Microscopy and Histopathology Study on 77 Patients.

Starace M, Mandel V, Ardigo M, Carpanese M, Quadrelli F, Pampaloni F Dermatol Ther (Heidelb). 2025; .

PMID: 40064753 DOI: 10.1007/s13555-025-01378-2.


Trichoscopic Findings Post Hair Restoration Surgery.

Bloch L, Rocchetto H Skin Appendage Disord. 2023; 9(4):306-308.

PMID: 37564684 PMC: 10410068. DOI: 10.1159/000530856.


Beard Alopecia: An Updated and Comprehensive Review of Etiologies, Presentation and Treatment.

Kaiser M, Abdin R, Yaghi M, Gaumond S, Jimenez J, Issa N J Clin Med. 2023; 12(14).

PMID: 37510908 PMC: 10381635. DOI: 10.3390/jcm12144793.


The use of photobiomodulation therapy for the management of chemotherapy-induced alopecia: a randomized, controlled trial (HAIRLASER trial).

Lodewijckx J, Robijns J, Claes M, Pierson M, Lenaerts M, Mebis J Support Care Cancer. 2023; 31(5):269.

PMID: 37060420 DOI: 10.1007/s00520-023-07743-1.


Intermittent chronic telogen effluvium with an unusual dermoscopic finding following COVID-19.

Saki N, Sari Aslani F, Sepaskhah M, Shafiei M, Alavizadeh S, Hosseini S Clin Case Rep. 2022; 10(8):e6228.

PMID: 35957778 PMC: 9361802. DOI: 10.1002/ccr3.6228.